Robert C. Stein
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 29
- Oncology 10
- Co-authors
- Michael Derek Waterfield (10 shared papers)Raoul Charles Coombes (26 shared papers)Marketa Zvelebil (10 shared papers)Jong B. Kim (3 shared papers)M.J. O’Hare (3 shared papers)Stefano Volinia (5 shared papers)Mitch Dowsett (11 shared papers)Bart Vanhaesebroeck (4 shared papers)
- Journals
- British Journal of Cancer (8 papers)European Journal of Cancer (7 papers)Trials (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United KingdomCanadaBelgium
In The Last Decade
Robert C. Stein
95 papers receiving 6.7k citations
Robert C. Stein's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 1.3k
- Oncology 1.1k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 850
- Cell Biology 360
Countries citing papers authored by Robert C. Stein
This map shows the geographic impact of Robert C. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Stein more than expected).
Fields of papers citing papers by Robert C. Stein
This network shows the impact of papers produced by Robert C. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Stein. The network helps show where Robert C. Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert C. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 565 | |
| 2 | 2002 | 445 | |
| 3 | 1997 | 383 | |
| 4 | 2013 | 352 | |
| 5 | Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial Hit paper breakdown → | 2019 | 330 |
| 6 | 2006 | 320 | |
| 7 | 1995 | 318 | |
| 8 | 2004 | 262 | |
| 9 | 1997 | 220 | |
| 10 | 2018 | 181 | |
| 11 | 2000 | 170 | |
| 12 | 1999 | 169 | |
| 13 | 2016 | 165 | |
| 14 | 2011 | 151 | |
| 15 | 2003 | 133 | |
| 16 | Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. | 1989 | 130 |
| 17 | 2007 | 120 | |
| 18 | 2007 | 119 | |
| 19 | 2001 | 116 | |
| 20 | 1998 | 111 |
About Robert C. Stein
Robert C. Stein is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Spectroscopy, having authored 98 papers that have together received 7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (29 papers), PI3K/AKT/mTOR signaling in cancer (12 papers), Estrogen and related hormone effects (12 papers), Ethics in Clinical Research (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Advanced Proteomics Techniques and Applications (5 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.1k citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (850 citations) and Cell Biology (360 citations). Robert C. Stein has collaborated with scholars based in United Kingdom, Canada and Belgium. Frequent co-authors include Michael Derek Waterfield, Raoul Charles Coombes, Marketa Zvelebil, Jong B. Kim, M.J. O’Hare, Stefano Volinia, Mitch Dowsett, Bart Vanhaesebroeck, Jan Domin and Julian Downward. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Trials, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.